基本信息:
- 专利标题: ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
- 专利标题(中):PROSTAGLANDIN D2受体的拮抗剂
- 申请号:PCT/US2009049621 申请日:2009-07-02
- 公开(公告)号:WO2010003120A3 公开(公告)日:2010-04-29
- 发明人: HUTCHINSON JOHN HOWARD , SEIDERS THOMAS JON , WANG BOWEI , ARRUDA JEANNIE M , STEARNS BRIAN ANDREW
- 申请人: AMIRA PHARMACEUTICALS INC , HUTCHINSON JOHN HOWARD , SEIDERS THOMAS JON , WANG BOWEI , ARRUDA JEANNIE M , STEARNS BRIAN ANDREW
- 专利权人: AMIRA PHARMACEUTICALS INC,HUTCHINSON JOHN HOWARD,SEIDERS THOMAS JON,WANG BOWEI,ARRUDA JEANNIE M,STEARNS BRIAN ANDREW
- 当前专利权人: AMIRA PHARMACEUTICALS INC,HUTCHINSON JOHN HOWARD,SEIDERS THOMAS JON,WANG BOWEI,ARRUDA JEANNIE M,STEARNS BRIAN ANDREW
- 优先权: US7831108 2008-07-03
- 主分类号: C07C323/57
- IPC分类号: C07C323/57 ; A61K31/10 ; A61K31/167 ; A61P11/00 ; A61P37/08 ; C07C321/20
摘要:
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
摘要(中):
本文描述的是作为PGD 2受体拮抗剂的化合物。 还描述了包括本文所述化合物的药物组合物,以及将PGD2受体单独或与其它化合物组合使用的这些拮抗剂用于治疗呼吸,心血管和其它PGD2依赖性或PGD2介导的病症或疾病的方法。
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07C | 无环或碳环化合物 |
------C07C323/00 | 被卤素、氧或氮原子或非硫代基硫原子取代的硫醇、硫醚、氢化多硫化物或多硫化物 |
--------C07C323/23 | .硫代基和不属于硝基或亚硝基氮原子连接在同一碳架上 |
----------C07C323/51 | ..有硫代基的硫原子连接在碳架的非环碳原子上 |
------------C07C323/57 | ...碳架进一步被不属于硝基或亚硝基的氮原子取代 |